Managing Director at Consort Partners | Recovering sports, entertainment, tech editor & writer l Cool uncle
Illinois
Joined June 2009
- Tweets86.8K
- Following903
- Followers4.5K
- Likes5.2K
Patrick Schmidt retweeted
DAAAAA BEARSSSSSS!! We are otw!! 🐻#18
Patrick Schmidt retweeted
Welcome to Chicago, @CALEBcsw! 🐻⬇️
Patrick Schmidt retweeted
“Our mission at Kyverna is all about caring for autoimmune disease patients with our novel and modern cell therapy approach.” 🧬
@Kyverna_Tx CEO Peter Maag shares with @NasdaqExchange how #NasdaqListed $KYTX is transforming how autoimmune diseases are treated.
Patrick Schmidt retweeted
Ultima Genomics Says UG 100 Sequencer Ready for Prime Time in High-Throughput Applications. At the annual AGBT General Meeting, early Ultima customers shared their experiences using the new instrument to satisfy their most sequencing-intensive... ow.ly/yrPO105fyUu
Patrick Schmidt retweeted
Exclusive: @UltimaGenomics , a "dark horse" in DNA sequencing, is a week away from launching an instrument that can read a genome for $100. Product details and more in my latest for @statnews + an interview with an early-access user
statnews.com/2024/01/30/ulti…
Patrick Schmidt retweeted
.@endpts wrote about @Kyverna_Tx’s Ingenui-T method for #autoimmune CAR T #celltherapy manufacturing using a streamlined “vein-to-vein” process that requires less blood and a fraction of the time for higher yields.
Read more: endpts.com/kyverna-says-car-…
Patrick Schmidt retweeted
.@alisonkanski in @GenomeWeb reports on a study from the Health Nevada Project in partnership with @my_helix which found some patients may safely defer #breastcancer #mammogram screening by up to 10 years beyond the recommended age of 40.
Read more: genomeweb.com/cancer/healthy…
Patrick Schmidt retweeted
.@maxonwifi in @FierceBiotech reports on @Kyverna_Tx’s latest @US_FDA fast-track designation for the company’s lead asset, KYV-101, in the treatment of progressive #multiplesclerosis
Read more: fiercebiotech.com/biotech/ky…
Patrick Schmidt retweeted
Freespira CEO Joseph Perekupka talks to @STAT's @mariojoze about the company's business model that focuses on partnerships with payers and the importance of winning @Point32Health's innovation challenge. #HealthcareInnovation #medtech
statnews.com/2024/01/18/digi…
Patrick Schmidt retweeted
.@FierceHealth’s @HeatherLandi wrote about the latest financing rounds across the healthcare industry, including precision #neurology software and data company Rune Labs’ $12 million strategic round, led by Nexus NeuroTech.
Read more:
fiercehealthcare.com/digital…
Patrick Schmidt retweeted
.@Forbes' Naveen Rao dives deep into all of the latest #neurotechnology insights from #JPM last week, including Rune Labs’ $12M strategic funding round led by Nexus NeuroTech.
Read more: forbes.com/sites/naveenrao/2…
Patrick Schmidt retweeted
.@FortuneMagazine's @jessicakmathews has the latest news of Rune Labs’ $12M strategic funding round led by Nexus NeuroTech.
Read more: fortune.com/2024/01/16/ventu…
Patrick Schmidt retweeted
Speaking with @Bloomberg Business of Sports, former @NBA star @MettaWorld37 shares more about the #betting platform Sparket, the room for growth in the betting space, and the NBA potentially hosting a team in Las Vegas.
#gambling #sports
bloomberg.com/news/audio/202…